Donald C. Carpenter - Concepedia

Author

Donald C. Carpenter

GlaxoSmithKline (United Kingdom)

Also Known As

DONALD CARPENTER, Donald C Carpenter, Donald C. Carpenter, Donald Carpenter

Publications

615

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)GlaxoSmithKline (United States)New Frontier

About

Donald C. Carpenter is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, inflammation, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	174
2	Cell Biology	3	3	90
3	Health Sciences	1	1	54
4	Natural Sciences	1	1	13
5	Biochemistry	1	1	13

Donald C. Carpenter

Publications

607

Citations

H-Index

Page 1

	Year	Citations
SB 239063, a Potent p38 MAP Kinase Inhibitor, Reduces Inflammatory Cytokine Production, Airways Eosinophil Infiltration, and Persistence David C. Underwood, Ruth R. Osborn, Charles J. Kotzer, Journal of Pharmacology and Experimental Therapeutics	2000	244
The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects Bruce E. Miller, Sunil Mistry, Kevin Smart, BMC Pharmacology and Toxicology	2015	63
A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: Upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist Grant C. Nicholson, Rachel Tennant, Donald C. Carpenter, Pulmonary Pharmacology & Therapeutics InflammationChemokine ReceptorNeutrophil Shape ChangeGranulocyteMedicine	2006	54
Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660) Bruce E. Miller, Ruth J. Mayer, Navin Goyal, British Journal of Clinical Pharmacology	2017	53
Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2 Jakob Busch‐Petersen, Donald C. Carpenter, Miriam Burman, Journal of Pharmacology and Experimental Therapeutics Chemokine BiologyImmune RegulationImmunologyPharmacotherapyCellular Physiology	2017	44
T cell depletion protects against alveolar destruction due to chronic cigarette smoke exposure in mice Patricia L. Podolin, Joseph P. Foley, Donald C. Carpenter, American Journal of Physiology-Lung Cellular and Molecular Physiology	2013	40
Modulation of HLA-DR Expression in Epithelial Cells by Interleukin 1 and Estradiol-17<i>β</i>* Siamak Tabibzadeh, Arunthathy Sivarajah, Donald C. Carpenter, The Journal of Clinical Endocrinology & Metabolism	1990	33
Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation Hugh M. Davis, Donald C. Carpenter, Jocelyn M Stahl, Journal of Immunological Methods InflammationCytokineAutoimmune DiseaseGranulocyteImmunology	2000	28
Inhibition of Invariant Chain Processing, Antigen-Induced Proliferative Responses, and the Development of Collagen-Induced Arthritis and Experimental Autoimmune Encephalomyelitis by a Small Molecule Cysteine Protease Inhibitor Patricia L. Podolin, Brian Bolognese, Donald C. Carpenter, The Journal of Immunology ImmunologyImmunologic MechanismAntigen ProcessingT CellsImmune System	2008	18
Zyn-Linked colchicines: Controlled-release lipophilic prodrugs with enhanced antitumor efficacy Margaret Baker, Brian D. Gray, Betsy M. Ohlsson‐Wilhelm, Journal of Controlled Release Cell-based Drug DeliveryMedicinal ChemistryMedicineZyn-linked ColchicinesPharmacology	1996	17

Page 1